See more : 2G Energy AG (ZGBEF) Income Statement Analysis – Financial Results
Complete financial analysis of Deinove SA (DNVVF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Deinove SA, a leading company in the Biotechnology industry within the Healthcare sector.
- JW Pharmaceutical Corporation (001060.KS) Income Statement Analysis – Financial Results
- Yang Ming Marine Transport Corporation (2609.TW) Income Statement Analysis – Financial Results
- KSB Limited (KSB.BO) Income Statement Analysis – Financial Results
- Abraxas Petroleum Corporation (AXAS) Income Statement Analysis – Financial Results
- Supermax Corporation Berhad (7106.KL) Income Statement Analysis – Financial Results
Deinove SA (DNVVF)
About Deinove SA
DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers PHYT-N-Resist, an anti-aging active ingredient for cosmetics; Luminity, a carotenoid-based ingredient to absorb blue light and exceptional antioxidant properties; HEBELYS, a natural active ingredient produced by fermentation of Sphingomonas; and BIOME Oléoactif, which acts as a post-biotic extract with a prebiotic effect to balance the skin microbiota. In addition, the company develops a process for producing natural ingredients for animal feed. DEINOVE SA has partnership agreements primarily with bioMérieux, Naicons, Medpace, Institut Pasteur, Hallstar Group, Sharon Laboratories, Oléos-Hallstar, Greentech, and Avril. The company was founded in 2006 and is headquartered in Grabels, France.
Source: https://incomestatements.info
Category: Stock Reports